IQV Iqvia Holdings Inc

  1. Stocks
  2. Healthcare
  3. NYSE: IQV

Price (delayed)

$257.25

Market cap

$49.14B

P/E Ratio

64.31

Dividend/share

N/A

EPS

$4

Enterprise value

$60.17B

IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development ...

Highlights
The price to earnings (P/E) is 80% lower than the 5-year quarterly average of 316.5 and 26% lower than the last 4 quarters average of 87.3
IQV's EPS is up by 26% since the previous quarter
The quick ratio has decreased by 16% YoY and by 7% QoQ
The gross margin has decreased by 2.4% YoY
Sector: Healthcare
Industry: Diagnostics & Research
Website: https://ir.iqvia.com/
Peers: NWBO NRC

Key stats

What are the main financial stats of IQV
Market
Shares outstanding
191.04M
Market cap
$49.14B
Enterprise value
$60.17B
Valuations
Price to earnings (P/E)
64.31
Price to book (P/B)
8.46
Price to sales (P/S)
3.64
EV/EBIT
45.55
EV/EBITDA
22.56
EV/Sales
4.45
Earnings
Revenue
$13.54B
EBIT
$1.32B
EBITDA
$2.67B
Free cash flow
$2.37B
Per share
EPS
$4
Free cash flow per share
$12.37
Book value per share
$30.42
Revenue per share
$70.68
TBVPS
$31.84
Balance sheet
Total assets
$24.03B
Total liabilities
$18.2B
Debt
$12.5B
Equity
$5.83B
Working capital
-$313M
Liquidity
Debt to equity
2.14
Current ratio
0.94
Quick ratio
0.81
Net debt/EBITDA
4.13
Margins
EBITDA margin
19.7%
Gross margin
33.2%
Net margin
5.7%
Operating margin
9%
Efficiency
Return on assets
3.2%
Return on equity
13%
Return on invested capital
10.4%
Return on capital employed
6.9%
Return on sales
9.8%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

IQV stock price

How has the Iqvia Holdings stock price performed over time
Intraday
0.14%
1 week
3.54%
1 month
-1.67%
1 year
53.61%
YTD
43.58%
QTD
7.39%

Financial performance

How have Iqvia Holdings's revenue and profit performed over time
Revenue
$13.54B
Gross profit
$4.5B
Operating income
$1.22B
Net income
$767M
Gross margin
33.2%
Net margin
5.7%
IQV's operating income has surged by 100% year-on-year and by 10% since the previous quarter
Iqvia Holdings's operating margin has surged by 64% YoY and by 6% QoQ
Iqvia Holdings's net income has increased by 26% QoQ
IQV's revenue is up by 24% YoY and by 4.7% QoQ

Growth

What is Iqvia Holdings's growth rate over time

Valuation

What is Iqvia Holdings stock price valuation
P/E
64.31
P/B
8.46
P/S
3.64
EV/EBIT
45.55
EV/EBITDA
22.56
EV/Sales
4.45
The price to earnings (P/E) is 80% lower than the 5-year quarterly average of 316.5 and 26% lower than the last 4 quarters average of 87.3
IQV's EPS is up by 26% since the previous quarter
The stock's price to book (P/B) is 97% more than its 5-year quarterly average of 4.3 and 21% more than its last 4 quarters average of 7.0
The stock's price to sales (P/S) is 46% more than its 5-year quarterly average of 2.5 and 10% more than its last 4 quarters average of 3.3
IQV's revenue is up by 24% YoY and by 4.7% QoQ

Efficiency

How efficient is Iqvia Holdings business performance
The company's return on invested capital has surged by 104% YoY and by 17% QoQ
IQV's return on sales has surged by 58% year-on-year and by 10% since the previous quarter
IQV's return on assets is up by 28% since the previous quarter
The ROE has increased by 26% QoQ

Dividends

What is IQV's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for IQV.

Financial health

How did Iqvia Holdings financials performed over time
The total assets is 32% greater than the total liabilities
Iqvia Holdings's current ratio has decreased by 16% YoY and by 10% from the previous quarter
The quick ratio has decreased by 16% YoY and by 7% QoQ
Iqvia Holdings's debt is 114% more than its equity
The debt to equity has decreased by 2.3% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.